Back
4D Molecular Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
32
FDMT
4D Molecular Therapeutics
Last Price:
$4.22
Seasonality Move:
-32.29%
Sell
38
REGN
Regeneron Pharmaceuticals
Last Price:
$542.42
Seasonality Move:
8.08%
Sell
32
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
-
The current 4D Molecular Therapeutics [FDMT] share price is $4.22. The Score for FDMT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
FDMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $542.52. The Score for REGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $4.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $542.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.19 | Buy |
Relative Strength Index (14 RSI): | 52 | Buy |
Chaikin Money Flow: | -204821 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.98 - 4.38) | Buy |
Bollinger Bands (100): | (3.2 - 4.3) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 152.98 | Buy |
Relative Strength Index (14 RSI): | 49.6 | Sell |
Chaikin Money Flow: | -1023583 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (517.51 - 553.07) | Buy |
Bollinger Bands (100): | (524.52 - 649.08) | Sell |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.3 | Sell |
20-day SMA: | 4.15 | Buy |
50-day SMA: | 3.92 | Buy |
200-day SMA: | 5.43 | Sell |
8-day EMA: | 3.83 | Buy |
20-day EMA: | 2.55 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 0.37 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 554.89 | Sell |
20-day SMA: | 539.31 | Buy |
50-day SMA: | 544.21 | Sell |
200-day SMA: | 692.24 | Sell |
8-day EMA: | 493.87 | Buy |
20-day EMA: | 328.41 | Buy |
50-day EMA: | 167.43 | Buy |
200-day EMA: | 47.68 | Buy |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.28 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.44 per share, a decrease this year of $9.47 per share, and an increase next year of $4.05 per share.
4D Molecular Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |